FATE
Fate Therapeutics Inc
2.30$
-4.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 85.2% | 88.4% | 98.3% | 97.4% | 96.6% | 98.2% | 97.4% | 96.3% | 75.1% | 79.4% | 68.7% | 71.2% | 65.5% | 66.2% | 65.4% | |
| 81.3% | 82.0% | 97.2% | 95.9% | 95.4% | 93.2% | 84.5% | 89.4% | 33.0% | 26.9% | 14.5% | 8.7% | 8.3% | 8.2% | 14.6% | |
| 81.3% | 82.0% | 97.2% | 95.9% | 95.4% | 96.9% | 95.9% | 94.4% | 73.3% | 77.6% | 66.8% | 61.8% | 62.3% | 63.3% | 63.9% | |
| – | – | – | – | – | – | – | 0.2% | 0.4% | 0.9% | 0.9% | 5.5% | 0.4% | 0.8% | 0.3% | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | 0.0% | – | 0.0% | – | – | – | |
| 13.3% | 10.5% | 1.5% | 2.3% | 3.2% | 1.7% | 2.4% | 2.4% | 3.8% | 5.2% | 17.6% | 25.0% | – | – | – | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| 745.5% | 576.9% | 8.5% | 44.7% | 44.0% | 23.0% | 26.7% | 24.7% | 19.0% | 38.2% | 26.3% | 31.4% | 27.2% | 27.7% | 35.0% | |
| 46.8% | 43.8% | 8.3% | 8.9% | 19.8% | 16.0% | 10.5% | 12.8% | 9.2% | 13.7% | 8.8% | 16.2% | 7.7% | 8.7% | 11.3% | |
| 15.9% | 17.5% | 3.1% | 3.0% | 9.6% | 8.6% | 6.9% | 1.1% | 0.6% | 0.5% | 0.6% | 0.8% | 1.2% | 1.7% | 1.4% | |
| 23.7% | 11.1% | 1.2% | 1.3% | 1.5% | 1.0% | 1.6% | 2.0% | 1.9% | 1.0% | 0.9% | 1.2% | 0.9% | 2.1% | 0.8% | |
| 45.7% | 15.6% | 0.0% | 35.3% | 15.7% | 2.6% | 14.1% | 5.8% | – | – | – | – | – | – | – | |
| -645.5% | -476.9% | 91.5% | 55.3% | 56.0% | 77.0% | 73.3% | 75.3% | 81.0% | 61.8% | 73.7% | 68.6% | 72.8% | 72.3% | 65.0% | |
| -654.3% | -592.4% | -155.6% | -219.5% | -209.5% | -185.0% | -207.8% | -134.0% | -126.9% | -89.5% | -83.5% | -148.9% | -239.4% | -317.2% | -481.1% | |
| 112.9% | 80.1% | 35.5% | 39.9% | 37.5% | 33.4% | 39.9% | 26.4% | 22.6% | 13.2% | 10.3% | 13.7% | 19.4% | 25.8% | 37.2% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.